Supplemental data Figure 2S

Sep 20, 2014

10 likes | 128 Views

2.0 kb. 0.8 kb. 1.5 kb. 1.0 kb. 0.5 kb. B73 gDNA. Oat gDNA. OMAL 5. OMAL 1. OMAL 2. OMAL 3. OMAL 4. OMAL 6. OMAL 7. OMAL 8. OMAL 9. OMAL 10. B73 gDNA. Water. Supplemental data Figure 2S.

Share Presentation

Embed Code

Link

water
omal 3
omal 5
omal 8
omal 9
supplemental data figure 2s

hoang

Download Presentation

Supplemental data Figure 2S

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

2.0 kb 0.8 kb 1.5 kb 1.0 kb 0.5 kb B73 gDNA Oat gDNA OMAL 5 OMAL 1 OMAL 2 OMAL 3 OMAL 4 OMAL 6 OMAL 7 OMAL 8 OMAL 9 OMAL 10 B73 gDNA Water Supplemental data Figure 2S

Supplemental Figure 1

Supplemental Figure 1. Fig. S1 qRT -PCR analysis of the genes flanking the sbp2’ / sbp2’’ knockouts. All values are given relative to the abundance of transcript observed in P1/7. Data presents the mean from 3 biological replicates. .

101 views • 1 slides

Supplemental Figure 3

Supplemental Figure 3. Purified Collagens. A). B). Purified Collagen1 ( μ g). 0.12. 0.25. 0.5. 1. 2.5. 5. 10. 20. Purified Col1. Purified Col3. Col1. Purified Collagen3 ( μ g). Col1. 0.12. 0.25. 0.5. 1. 2.5. 5. 10. 20. Col3. Col3. Col1. Col3. Arbitrary Units.

122 views • 1 slides

Supplemental Figure 1

Supplemental Figure 1. d-ROM (Carr U). P = 0.0512. recurrence-free period (day). Correlation between d-ROM levels and recurrence-free period in 36 multicentric occurrence cases using linear regression analysis.

80 views • 1 slides

Supplemental Data Figure 1.

Supplemental Data Figure 1. Kaplan-Meier curves of time to Cardiovascular Death, subdivided into quartiles of cystatin C. Number of subjects at risk is presented below figure.

115 views • 1 slides

Supplemental Figure 1

Supplemental Figure 1.

76 views • 1 slides

Figure 2S

Figure 2S. 074.

86 views • 1 slides

Supplemental Figure 3

Supplemental Figure 3. Time course of mean arterial pressure, albuminuria, and kidney injury after reduction in renal mass and treatment of C57BL/6 mice with deoxycorticosterone acetate + saline drinking water (DOCA) or treatment of CD-1 mice with hydralazine.

135 views • 1 slides

Supplemental Data Figure 3

Supplemental Data Figure 3. PCSK9 WT V5 – Fluor 594. Fluor 488 + 594 + DAPI. PCSK9 WT His – Fluor 488. a. b. c. PCSK9 QH V5 – Fluor 594. Fluor 488 + 594 + DAPI. PCSK9 WT His – Fluor 488. d. e. f.

116 views • 1 slides

Supplemental Figure 1

Supplemental Figure 1. A. P-VEGFR2. Tubulin. PlGF-1 250 ng/mL - + + + + Time (min) - 5 10 15 30. B. P-VEGFR2. Tubulin. C.

95 views • 3 slides

Supplemental Figure 5

Supplemental Figure 5. A. MTLn3 GFP-CXCL12. MTLn3 GFP-pQCXIP. C. B. ***. CXCR4. IgG. % of max. BMM Chemotaxis to CXCL12. % of max. CXCR4-PE. CXCR4-PE. IgG. CXCR4. B.

118 views • 1 slides

Supplemental Data - Figure 1.

115 views • 1 slides

Supplemental Figure 5

Trastuzumab-treated. Control-treated. A. MDA-MB-453. 14.2%. 10.7%. DEAB-inhibited. DEAB-inhibited. B. JIMT-1. 5.2%. 5.4%. DEAB-inhibited. DEAB-inhibited. C. Sum159-HER2. 7.1%. 36%. DEAB-inhibited. DEAB-inhibited. Trastuzumab-treated. Control-treated. D. Supplemental Figure 5.

134 views • 1 slides

Supplemental Figure 2

si RNA #1. si RNA #1. si RNA #1. si RNA #1. si RNA #2. si RNA #2. si RNA #2. si RNA #2. si RNA #3. si RNA #3. si RNA #3. si RNA #3. si control. si control. si control. si control. Casp-9. Casp-2. 47kDa. 51kDa. b -actin. b -actin. Relative mRNA expression. RAIDD. PIDD.

129 views • 1 slides

Supplemental Data Figure 2

Supplemental Data Figure 2.

83 views • 1 slides

Supplemental Data Figure 1

A. 1000. 8000. 800. hs-cTnT (corrected) [ng/L]. 6000. 600. 4000. 400. 0. 2000. 4000. 6000. 8000. hs-cTnT (original) [ng/L]. B. 200. 2000. 0. 0. hs-cTnT (corrected) [ng/L]. 0. 200. 400. 600. 800. 1000. hs-cTnT (original) [ng/L]. C. 100. 80.

84 views • 1 slides

Supplemental Figure 1

Supplemental Figure 1. True leaf from 2 nd to 7 th nodes. (a). M. 1 st (IN) IN. 2 nd. 3 rd. 4 th. 5 th. 6 th. 7 th. PC. ALSV-RNA2. 7. PsEF1- a. 6. 1. 2. 3. 5. True leaf from 2 nd to 7 th nodes. ALSV inoculation. 4. 2 nd. 3 rd. 4 th. 5 th. 6 th. 7 th. 3. Mock. 2.

98 views • 3 slides

Supplemental Figure.

Supplemental Figure. Legend:

91 views • 3 slides

Supplementary Figure 2S

Supplementary Figure 2S. TMZ. NEO212. [ U251TR ]. 125. 100. 75. % Apoptosis. 50. 25. 0. 0. 20. 40. 60. 80. 100. Concentrations [ m M ].

128 views • 1 slides

Supplemental data Figure 1

100. 100. *. *. Jurkat. 80. 80. PBMC. 60. 60. % Apoptosis. 40. 40. 20. 20. 0. 0. PHA + 100 nmol/L Dig. PHA + 10 nmol/L Dig. Untreated. PHA. Supplemental data Figure 1.

159 views • 1 slides

Supplemental Figure 3

Supplemental Figure 3.

76 views • 1 slides

Figure I supplemental

Figure I supplemental.

172 views • 6 slides

Supplemental Figure 2

Supplemental Figure 2. a. ADP titration (Clark-type electrode). ~10.00. ~10.27. ~7.01. ~5.11. ~5.00. ~4.03. ADP titration (Seahorse XF24). b. ~3.89. ~3.10. ~2.62. ~2.03. ~1.63. c. Mitochondrial integrity test (Clark-type electrode). d.

116 views • 2 slides

More Related